Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Everyman upbeat about upcoming releases as H1 profits rise

(Sharecast News) - Everyman Media shares bounced back following recent falls on Thursday after the cinema chain pointed to improving conditions in the second half on the back of a strong pipeline of releases.

The upmarket cinema operator, which owns 45 sites across the UK with two more in the works this year, said high-profile releases over the remainder of 2024 like Joker: Folie à Deux, Paddington in Peru and Gladiator II should result in a "significant H2 weighting to admissions, revenue and EBITDA".

Admissions in the first half totalled 1.9m, up from 1.6m the year before, leading to revenues rising to £46.9m from £38.3m, while average ticket prices increased to £11.76 from £11.49 a year earlier. EBITDA rose to £6.2m from £5.8m.

"Our continued strong performance, driven by consumer appetite for the unique Everyman proposition, comes despite a marked reduction in film output following last year's writer and actor strikes," said chief executive Alex Scrimgeour.

Everyman said it expects to hit market expectations for the year ending 2 January 2025 of £108m in revenue and adjusted EBITDA of £19.3m, up from £90.9m and £16.2m the previous year, respectively.

The stock was up nearly 5% at 51.45p by 1050 BST, but still remained down 20% over the year to date.

Share this article

Related Sharecast Articles

Smith & Nephew appoints Ajay Dhankhar as chief corporate development & strategy officer
(Sharecast News) - Medical technology company Smith & Nephew said on Monday that it has appointed Ajay Dhankhar as chief corporate development & strategy officer with immediate effect.
Oxford Biomedica acquires last 10pc stake in US subsidiary
(Sharecast News) - Oxford Biomedica said on Monday it has acquired the remaining 10% stake in its US subsidiary, OXB US, from Q32 Bio, bringing its ownership of the business to 100% as previously planned.
PPHE acquiring prime London site for hotel development
(Sharecast News) - PPHE Hotel Group has announced the acquisition of a prime development site near the City of London, where it plans to build its first Radisson RED select service hotel in the capital.
Norcros to end tile production in South Africa
(Sharecast News) - Norcros announced on Monday that it will shut down manufacturing at Johnson Tiles South Africa at the end of June, following the conclusion of a strategic review.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.